Dr. Pamela Munster
Claim this profileUniversity of California, San Francisco
Expert in Tumors
Studies Solid Tumors
18 reported clinical trials
36 drugs studied
About Pamela Munster
Education:
- Earned an MD from the University of Basel, Switzerland, in 1987.
- Obtained a PhD in Experimental Pathology from the University of Basel, Switzerland, in 1992.
Experience:
- Serves as a Professor of Medicine and Director of the Early Phase Clinical Trials Program at the University of California, San Francisco (UCSF).
- Co-Leader and Founding Member of the UCSF Center for BRCA Research.
- Active member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).
- Specializes in early phase clinical trials, cancer genetics, and targeted therapies for breast and ovarian cancers.
Area of expertise
1Tumors
Global LeaderStage IV
HER2 positive
Stage III
2Solid Tumors
Stage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Pamela Munster is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
HRO761 + Other Drugs
for MSI-H Cancers
This trial is testing a new drug called HRO761, which targets a protein that helps cancer grow. It is for patients with specific types of cancer that might respond better to this treatment. The study will find the best dose of HRO761 alone and with other drugs, and see how well it works.
Recruiting1 award Phase 1
More about Pamela Munster
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Pamela Munster has experience with
- Pembrolizumab
- Irinotecan
- Niraparib
- BB-1701
- PC14586
- Nab Paclitaxel
Breakdown of trials Pamela Munster has run
Tumors
Solid Tumors
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pamela Munster specialize in?
Pamela Munster focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are HER2 positive.
Is Pamela Munster currently recruiting for clinical trials?
Yes, Pamela Munster is currently recruiting for 8 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Pamela Munster has studied deeply?
Yes, Pamela Munster has studied treatments such as Pembrolizumab, Irinotecan, Niraparib.
What is the best way to schedule an appointment with Pamela Munster?
Apply for one of the trials that Pamela Munster is conducting.
What is the office address of Pamela Munster?
The office of Pamela Munster is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.